Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …

Background Adherence to direct oral anticoagulants (DOACs) in patients with atrial
fibrillation in every day practice may be less than in clinical trials. Aims To assess adherence …

Abstract Purpose Direct oral anticoagulants (DOACs) have been promoted in patients with
nonvalvular atrial fibrillation (nv‐AF) as a more convenient alternative to vitamin K …

Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …

BACKGROUND: Primary nonadherence (not filling a first prescription) is an important yet
unstudied aspect of adherence to oral anticoagulant (OAC) therapy. OBJECTIVE: To …

Introduction Medications cannot exert their effect if not taken as prescribed by patients. Our
objective was to summarise the observational evidence on adherence to oral anticoagulants …

Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke
prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence …

Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …

BACKGROUND: Direct oral anticoagulants (DOACs) are widely used for the prevention of
stroke in nonvalvular atrial fibrillation (NVAF); however, real-world primary nonadherence …

Background and Purpose Data on oral anticoagulant (OAC) uptake and pattern of use are
limited. Real‐life data in patients with atrial fibrillation (AF) are important for understanding …